Total Payments
$38,243
2024 Payments
$4,102
Companies
47
Transactions
1,666
Medicare Patients
6,629
Medicare Billing
$622,001
Payment Breakdown by Category
Food & Beverage$28,608 (74.8%)
Other$9,250 (24.2%)
Education$385.12 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $28,608 | 1,640 | 74.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,250 | 7 | 24.2% |
| Education | $385.12 | 19 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $12,114 | 121 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $4,091 | 321 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,990 | 153 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $2,407 | 122 | $0 (2024) |
| Amgen Inc. | $2,240 | 102 | $0 (2024) |
| PFIZER INC. | $1,813 | 148 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,594 | 73 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,409 | 101 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,153 | 53 | $0 (2024) |
| Amarin Pharma Inc. | $1,060 | 73 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,102 | 199 | AstraZeneca Pharmaceuticals LP ($892.50) |
| 2023 | $3,450 | 197 | AstraZeneca Pharmaceuticals LP ($441.22) |
| 2022 | $4,313 | 250 | Esperion Therapeutics, Inc. ($427.78) |
| 2021 | $3,577 | 229 | Janssen Pharmaceuticals, Inc ($651.19) |
| 2020 | $11,317 | 161 | AstraZeneca Pharmaceuticals LP ($9,128) |
| 2019 | $3,814 | 202 | Janssen Pharmaceuticals, Inc ($678.21) |
| 2018 | $3,907 | 218 | Novartis Pharmaceuticals Corporation ($638.64) |
| 2017 | $3,763 | 210 | Janssen Pharmaceuticals, Inc ($767.05) |
All Payment Transactions
1,666 individual payment records from CMS Open Payments — Page 1 of 67
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Cardiology | ||||||
| 12/13/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $78.64 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/02/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: Cardiology | ||||||
| 11/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $15.95 | General |
| 11/19/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $115.48 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/11/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.64 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $33.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiology | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.80 | General |
| Category: Cardiovascular | ||||||
| 10/22/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: Cardiology | ||||||
| 10/20/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $27.97 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,338 | 2,232 | $426,782 | $135,541 |
| 2022 | 12 | 1,378 | 2,279 | $455,962 | $151,886 |
| 2021 | 20 | 1,716 | 2,638 | $472,346 | $170,938 |
| 2020 | 33 | 2,197 | 3,518 | $307,240 | $163,637 |
Total Patients
6,629
Total Services
10,667
Medicare Billing
$622,001
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 356 | 800 | $194,400 | $65,054 | 33.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 65 | 65 | $50,430 | $18,586 | 36.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 133 | 136 | $58,501 | $15,325 | 26.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 41 | 164 | $20,172 | $7,194 | 35.7% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 56 | 114 | $26,106 | $6,289 | 24.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 376 | 622 | $23,014 | $5,931 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $16,536 | $5,586 | 33.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 31 | 31 | $10,620 | $3,735 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 53 | $9,116 | $2,958 | 32.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 52 | 53 | $10,547 | $2,457 | 23.3% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 26 | 26 | $4,940 | $1,242 | 25.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 63 | 77 | $770.00 | $639.13 | 83.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 17 | 17 | $816.00 | $252.18 | 30.9% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 11 | 11 | $528.00 | $199.10 | 37.7% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 11 | 11 | $286.00 | $94.05 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 378 | 845 | $181,922 | $66,828 | 36.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 71 | 71 | $60,060 | $22,712 | 37.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 150 | 152 | $71,447 | $19,018 | 26.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 55 | 220 | $25,500 | $10,684 | 41.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2022 | 76 | 147 | $33,663 | $8,071 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $21,574 | $6,977 | 32.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 385 | 564 | $20,868 | $5,074 | 24.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 30 | 30 | $10,181 | $3,652 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 60 | $8,920 | $3,509 | 39.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 70 | 73 | $14,527 | $3,366 | 23.2% |
About Dr. Raul Heredia, MD
Dr. Raul Heredia, MD is a Cardiovascular Disease healthcare provider based in Frankfort, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366408213.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raul Heredia, MD has received a total of $38,243 in payments from pharmaceutical and medical device companies, with $4,102 received in 2024. These payments were reported across 1,666 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($28,608).
As a Medicare-enrolled provider, Heredia has provided services to 6,629 Medicare beneficiaries, totaling 10,667 services with total Medicare billing of $622,001. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Frankfort, KY
- Active Since 04/20/2006
- Last Updated 12/27/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1366408213
Products in Payments
- FARXIGA (Drug) $10,591
- XARELTO (Drug) $4,091
- ENTRESTO (Drug) $2,537
- LifeVest (Device) $2,407
- ELIQUIS (Drug) $1,998
- Repatha (Biological) $1,687
- JARDIANCE (Drug) $1,167
- Vascepa (Drug) $1,060
- VYNDAQEL (Drug) $767.46
- BRILINTA (Drug) $744.45
- MULTAQ (Drug) $718.37
- Kerendia (Drug) $697.86
- VERQUVO (Drug) $653.79
- NEXLETOL (Drug) $600.66
- Corlanor (Drug) $542.67
- LEQVIO (Drug) $452.85
- PRALUENT (Drug) $434.45
- Ozempic (Drug) $416.63
- PRADAXA (Drug) $391.55
- Edarbi (Drug) $331.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Frankfort
David Sihau, Md, MD
Cardiovascular Disease — Payments: $135,653
Cardiovascular Disease $135,653
Dr. Robert Hammons
Cardiovascular Disease — Payments: $839.68
Cardiovascular Disease $839.68
Grover Tussey, M.d, M.D
Cardiovascular Disease — Payments: $193.96
Cardiovascular Disease $193.96
Dr. Andrew Bustin, Md, MD
Cardiovascular Disease
Cardiovascular Disease